Worth Venture Partners »

Vaccinex shares owned by Worth Venture Partners

Quarter-by-quarter ownership of Vaccinex shares owned by Worth Venture Partners from 13F filings

Historical chart of Worth Venture Partners investment in Vaccinex

Tip: Access up to 7 years of quarterly data

All positions including Vaccinex held by Worth Venture Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaccinex by Worth Venture Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $435k 654k 0.66
2023-09-30 $811k 718k 1.13

More positions owned by Worth Venture Partners

Bloomin Brands Note 5.000% 5/0 (Principal)
Livent Corp Note 4.125% 7/1 (Principal)
Royal Caribbean Group Note 6.000% 8/1 (Principal)
Myomo Com New (MYO)
Aspen Aerogels (ASPN)
Chart Inds Note 1.000%11/1 (Principal)
Progress Software Corp Note 1.000% 4/1 (Principal)
Scpharmaceuticals (SCPH)
Indie Semiconductor Class A Com (INDI)
Veradigm Note 0.875% 1/0 (Principal)
Transphorm (TGAN)
Transocean Deb 4.625% 9/3 (Principal)
Sarepta Therapeutics DBCV 1.500%11/1 (Principal)
Ouster Com New (OUST)
Geo Corrections Holdings Note 6.500% 2/2 (Principal)

View all positions for Worth Venture Partners

Top funds holding Vaccinex

AIGH Capital Management
Worth Venture Partners
Two Sigma Investments
UBS Group
Royal Bank of Canada
Bank of America Corporation

View all funds holding Vaccinex